Divergence in NK cell and cyclic AMP regulation of T cell CD40L expression in asthmatic subjects

Journal of Leukocyte Biology

Volumn 74, Issue 4, 2003, Pages 531-541

  Wingett, Denise ^a,b,c,d   Nielson, Christopher P ^a,b,c  

^a Boise VA Medical Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c St Luke's Boise Regional Medical Center   (United States)

^d BOISE STATE UNIVERSITY   (United States)

Author keywords

Allergy; CAMP; Cellular activation

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CD40 LIGAND; CYCLIC AMP; FAS ANTIGEN; SALMETEROL;

ANTIGEN EXPRESSION; ARTICLE; ASTHMA; CELL CONTACT; CELL LOSS; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGENS, CD45; ANTIGENS, CD95; ASTHMA; CD40 LIGAND; CELLS, CULTURED; CYCLIC AMP; HUMANS; KILLER CELLS, NATURAL; T-LYMPHOCYTES;

EID: 0347991976     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0303103     Document Type: Article

References (67)

1. Azzawi, M., Bradley, B., Jeffery, P. K., Frew, A. J., Wardlaw, A. J., Knowles, G., Assoufi, B., Collins, J. V., Durham, S., Kay, A. B. (1990) Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142, 1407-1413.
2. Corrigan, C. J., Kay, A. B. (1990) CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am. Rev. Respir. Dis. 141, 970-977.
3. Walker, C., Virchow, J. C. J., Iff, T., Bruijnzeel, P. L., Blaser, K. (1991) T cells and asthma. I. Lymphocyte subpopulations and activation in allergic and nonallergic asthma. Int. Arch. Allergy Appl. Immunol. 94, 241-243.
4. Robinson, D. S., Ying, S., Bentley, A. M., Meng, Q., North, J., Durham, S. R., Kay, A. B., Hamid, Q. (1993) Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92, 397-403.
5. Virchow, J. C. J., Walker, C., Hafner, D., Kortsik, C., Werner, P., Matthys, H., Kroegel, C. (1995) T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am. J. Respir. Crit. Care Med. 151, 960-968.
6. Gavett, S. H., Chen, X., Finkelman, F., Wills-Karp, M. (1994) Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10, 587-593.
7. Krinzman, S. J., De Sanctis, G. T., Cernadas, M., Mark, D., Wang, Y., Listman, J., Kobzik, L., Donovan, C., Nassr, K., Katona, I., Christiani, D. C., Perkins, D. I., Finn, P. W. (1996) Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J. Clin. Invest. 98, 2693-2699.
8. Wills-Karp, M. (1999) Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17, 255-281.
9. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., Van Kooten, C., Liu, Y. J., Rousset, F., Saeland, S. (1994) The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
10. Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., Aruffo, A. (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11, 4313-4321.
11. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263-1272.
12. Rousset, F., Garcia, E., Banchereau, J. (1991) Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 173, 705-710.
13. Zhang, K., Clark, E. A., Saxon, A. (1991) CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J. Immunol. 146, 1836-1842.
14. Lederman, S., Yellin, M. J., Cleary, A. M., Pernis, A., Inghirami, G., Cohn, L. E., Covey, L. R., Lee, J. J., Rothman, P., Chess, L. (1994) T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J. Immunol. 152, 2163-2171.
15. Kennedy, M. K., Mohler, K. M., Shanebeck, K. D., Baum, P. R., Picha, K. S., Otten-Evans, C. A., Janeway, C. A. J., Grabstein, K. H. (1994) Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 24, 116-123.
16. Ranheim, E. A., Kipps, T. J. (1993) Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177, 925-935.
17. Shinde, S., Wu, Y., Guo, Y., Niu, Q., Xu, J., Grewal, I. S., Flavell, R., Liu, Y. (1996) CD40L is important for induction of, but not response to, costimulatory activity, ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L. J. Immunol. 157, 2764-2768.
18. Nakstad, B., Kahler, H., Lyberg, T. (1999) Allergen-stimulated expression of CD154 (CD40 ligand) on CD3+ lymphocytes in atopic, but not in nonatopic individuals. Modulation by bacterial lipopolysaccharide. Allergy 54, 722-729.
19. Hermes, B., Worm, M., Nowak, F., Kroczek, R. A., Stein, H., Henz, B. M. (1997) Upregulation of CD40 and CD40 ligand expression in IgE-associated cutaneous diseases. Acta Derm. Venereol. 77, 441-445.
20. Markert, U. R., Bar, C., Niess, J. H., Vogelsang, H., Zwacka, G. (1999) Elevated CD154 (CD40 ligand) synthesis in T-cells from allergic patients after nonspecific stimulation in vitro. J. Investig. Allergol. Clin. Immunol. 9, 248-252.
21. Mehlhop, P. D., van de Rijn, M., Brewer, J. P., Kisselgof, A. B., Geha, R. S., Oettgen, H. C., Martin, T. R. (2000) CD40L, but not CD40, is required for allergen-induced bronchial hyperresponsiveness in mice. Am. J. Respir. Cell Mol. Biol. 23, 646-651.
22. Lei, X. F., Ohkawara, Y., Stampfli, M. R., Mastruzzo, C., Marr, R. A., Snider, D., Xing, Z., Jordana, M. (1998) Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice. J. Clin. Invest. 101, 1342-1353.
23. Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J. A., Noelle, R. J. (1993) The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 151, 2497-2510.
24. Splawski, J. B., Nishioka, J., Nishioka, Y., Lipsky, P. E. (1996) CD40 ligand is expressed and functional on activated neonatal T cells. J. Immunol. 156, 119-127.
25. Wingett, D. G., Forcier, K., Nielson, C. P. (1999) Regulation of CD40L expression by cyclic AMP: contrasting proinflammatory and inhibitory actions. Cell. Immunol. 192, 203-212.
26. Nielson, C. P., Wingett, D. (2002) Endothelial cell and cAMP regulation of T-cell CD40 ligand: relevance of calcium/calmodulin-dependent kinase IV signalling. Immunology 105, 430-440.
27. Young, J. L., Ramage, J. M., Gaston, J. S., Beverley, P. C. (1997) In vitro responses of human CD45R0brightRA- and CD45R0-RAbright T cell subsets and their relationship to memory and naive T cells. Eur. J. Immunol. 27, 2383-2390.
28. Sigova, A., Dedkova, E., Zinchenko, V., Litvinov, I. (1999) A comparative study of the calcium svstem in memory T cells and naive T cells. FEBS Lett. 447, 34-38.
29. Hall, S. R., Heffernan, B. M., Thompson, N. T., Rowan, W. C. (1999) CD4+ CD45RA+ and CD4+ CD45RO+ T cells differ in their TCR-associated signaling responses. Eur. J. Immunol. 29, 2098-2106.
30. Nagelkerken, L., Hertogh, H. A. (1992) The acquisition of a memory phenotype by murine CD4+ T cells is accompanied by a loss in their capacity to increase intracellular calcium. Dev. Immunol. 3, 25-34.
31. Schauer, U., Jung, T., Heymanns, J., Rieger, C. H. (1991) Imbalance of CD4+CD45R+ and CD4+CD29+ T helper cell subsets in patients with atopic diseases. Clin. Exp. Immunol. 83, 25-29.
32. Nasert, S., Burtchen, N., Kussebi, F., Millner, M., Kroczek, R., Jung, T., Schwinzer, R., Wahn, U., Renz, H. (1996) Stimulation of IgE and IgA production by CD45RA T helper cells in atopic patients. J. Immunol. 157, 441-448.
33. Patel, H. R., Oshiba, A., Jeppson, J. D., Gelfand, E. W. (1996) Differential expression of CD40 ligand on T cell subsets. Implications for different roles of CD45RA+ and CD45RO+ cells in IgE production. J. Immunol. 156, 1781-1787.
34. (1993) Guidelines for the evaluation of impairment/disability in patients with asthma. American Thoracic Society, Medical Section of the American Lung Association. Am. Rev. Respir. Dis. 147, 1056-1061.
35. (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am. Rev. Respir. Dis. 136, 225-244.
36. Coligan, J. E. (1995) Current Protocols in Immunology, John Wiley & Sons, Somerset, NJ, Chapter 5.1.
37. Peritt, D., Robertson, S., Gri, G., Showe, L., Aste-Amezaga, M., Trinchieri, G. (1998) Differentiation of human NK cells into NK1 and NK2 subsets. J. Immunol. 161, 5821-5824.
38. Mach, F., Schonbeck, U., Fabunmi, R. P., Murphy, C., Atkinson, E., Bonnefoy, J. Y., Graber, P., Libby, P. (1999) T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. Am. J. Pathol. 154, 229-238.
39. Malik, N., Greenfield, B. W., Wahl, A. F., Kiener, P. A. (1996) Activation of human monocytes through CD40 induces matrix metalloproteinases. J. Immunol. 156, 3952-3960.
40. Suarez, A., Mozo, L., Gutierrez, C. (2002) Generation of CD4(+)CD45RA(+) effector T cells by stimulation in the presence of cyclic adenosine 5′-monophosphate-elevating agents. J. Immunol. 169, 1159-1167.
41. Harada, Y., Miyatake, S., Arai, K., Watanabe, S. (1999) Cyclic AMP inhibits the activity of c-Jun N-terminal kinase (JNKp46) but not JNKp55) and ERK2 in human helper T lymphocytes. Biochem. Biophys. Res. Commun. 266, 129-134.
42. Takahashi, K., Miyake, S., Kondo, T., Terao, K., Hatakenaka, M., Hashimoto, S., Yamamura, T. (2001) Natural killer type 2 bias in remission of multiple sclerosis. J. Clin. Invest. 107, R23-R29.
43. Perez-Melgosa, M., Hollenbaugh, D., Wilson, C. B. (1999) Cutting edge: CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens. J. Immunol. 163, 1123-1127.
44. Hermann, P., Van Kooten, C., Gaillard, C., Banchereau, J., Blanchard, D. (1995) CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation. Eur. J. Immunol. 25, 2972-2977.
45. Kumagai, K., Ohno, I., Okada, S., Ohkawara, Y., Suzuki, K., Shinya, T., Nagase, H., Iwata, K., Shirato. K. (1999) Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J. Immunol. 162, 4212-4219.
46. Suzuki, R., Kato, T., Miyazaki, Y., Iwata, M., Noda, Y., Takagi, K., Nakashima, N., Torii, K. (2001) Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in sputum from patients with bronchial asthma. J. Asthma 38, 477-484.
47. Mattos, W., Lim, S., Russell, R., Jatakanon, A., Chung, K. F., Barnes, P. J. (2002) Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 122, 1543-1552.
48. Cataldo, D. D., Bettiol, J., Noel, A., Bartsch, P., Foidart, J. M., Louis, R. (2002) Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 122, 1553-1559.
49. Beasley, R., Pearce, N., Crane, J., Windom, H., Burgess, C. (1991) Asthma mortality and inhaled beta agonist therapy. Aust. N. Z. J. Med. 21, 753-763.
50. Beasley, R., Pearce, N., Crane, J., Burgess, C. (1999) Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J. Allergy Clin. Immunol. 104, S18-S30.
51. Kos, F. J. (1998) Regulation of adaptive immunity by natural killer cells. Immunol. Res. 17, 303-312.
52. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M., Tabira, T. (1997) Regulation of experimental autoimmuue encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186, 1677-1687.
53. Korsgren, M. (2002) NK cells and asthma. Curr. Pharm. Des. 8, 1871-1876.
54. Timonen, T., Stenius-Aarniala, B. (1985) Natural killer cell activity in asthma. Clin. Exp. Immunol. 59, 85-90.
55. Jira, M., Antosova, E., Vondra, V., Strejcek, J., Mazakova, H., Prazakova, J. (1988) Natural killer and interleukin-2 induced cytotoxicity in asthmatics. I. Effect of acute antigen-specific challenge. Allergy 43, 294-298.
56. Krejsek, J., Kral, B., Vokurkova, D., Derner, V., Touskova, M., Parakova, Z., Kopecky, O. (1998) Decreased peripheral blood gamma delta T cells in patients with bronchial asthma. Allergy 53, 73-77.
57. Vesterinen, E., Timonen, T. (1988) Natural killer cell activity in specific and non-specific bronchial challenge. Ann. Allergy 60, 247-249.
58. Walker, C., Checkel, J., Cammisuli, S., Leibson, P. J., Gleich, G. J. (1998) IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J. Immunol. 161, 1962-1969.
59. Korsgren, M., Persson, C. G., Sundler, F., Bjerke, T., Hansson, T., Chambers, B. J., Hong, S., Van Kaer, L., Ljunggren, H. G., Korsgren, O. (1999) Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 189, 553-562.
60. Todd, D. J., Greiner, D. L., Rossini, A. A., Mordes, J. P., Bortell, R. (2001) An atypical population of NK cells that spontaneously secrete IFN-gamma and IL-4 is present in the intraepithelial lymphoid compartment of the rat. J. Immunol. 167, 3600-3609.
61. Loza, M. J., Perussia, B. (2001) Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat. Immunol. 2, 917-924.
62. Loza, M. J., Peters, S. P., Zangrilli, J. G., Perussia, B. (2002) Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4. Eur. J. Immunol. 32, 413-423.
63. Lin, S. J., Chang, L. Y., Yan, D. C., Huang, Y. J., Lin, T. J., Lin, T. Y. (2003) Decreased intercellular adhesion molecule-1 (CD54) and L-selectin (CD62L) expression on peripheral blood natural killer cells in asthmatic children with acute exacerbation. Allergy 58, 67-71.
64. Deniz, G., Akdis, M., Aktas, E., Blaser, K., Akdis, C. A. (2002) Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells. Eur. J. Immunol. 32, 879-884.
65. Lee, Y. C., Lee, K. H., Lee, H. B., Rhee, Y. K. (2001) Serum levels of interleukins (IL)-4, IL-5, IL-13, and interferon-gamma in acute asthma. J. Asthma 38, 665-671.
66. Wilson, S. B., Byrne, M. C. (2001) Gene expression in NKT cells: defining a functionally distinct CD1d-restricted T cell subset. Curr. Opin. Immunol. 13, 555-561.
67. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J., Baxter, A. G. (2000) NKT cells: facts, functions and fallacies. Immunol. Today 21, 573-583.